RxDoctor Payments DataLook up a doctor →

Jennifer Woods

Clinical Nurse Specialist · Akron, OHNPI 1801815170

Payments from drug & device makers

$19,326in general payments, 2019–2025

Across 1,013 payments — averaging $19.08 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • AstraZeneca$2K
  • AbbVie$1K
  • Biogen$1K
  • Novartis$1K
  • Jazz Pharmaceuticals Inc.$918
  • UCB, Inc.$867
  • plus $12K from 54 others

General payments by program year

21
22
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

CompanyPaymentsTotal
AstraZeneca(2 entities)51$1,741
AbbVie104$1,441
Biogen58$1,080
Novartis87$1,079
Jazz Pharmaceuticals Inc.47$918
UCB, Inc.37$867
Harmony Biosciences LLC46$792
Sanofi18$726
SK Life Science, Inc.42$719
EMD Serono, Inc.42$671
Takeda Pharmaceuticals U.S.A., Inc.30$578
Neurocrine Biosciences, Inc.36$556
Genentech USA, Inc.29$519
Acadia Pharmaceuticals Inc24$499
Amgen(2 entities)25$488
Inspire Medical Systems, Inc.4$478
Teva Pharmaceuticals USA, Inc.32$421
Lundbeck LLC18$388
Johnson & Johnson(2 entities)15$325
Eisai Inc.16$319
Avadel CNS Pharmaceuticals, LLC7$311
Axsome Therapeutics, Inc.15$288
Merck15$266
TG Therapeutics, Inc.10$236
Biohaven Pharmaceuticals, Inc.5$232
Vanda Pharmaceuticals Inc.12$226
Salix Pharmaceuticals, A Division Of Bausch Health US, LLC15$216
Argenx US, Inc.9$189
Banner Life Sciences, LLC4$178
Supernus Pharmaceuticals, Inc.8$175
Neurelis, Inc.10$159
Impel Pharmaceuticals Inc.12$157
Biohaven Pharmaceutical Holding Company Ltd.7$125
Avion Pharmaceuticals11$124
Sumitomo Pharma America, Inc.12$121
Avanir Pharmaceuticals, Inc.6$120
Mallinckrodt Hospital Products Inc.4$120
Octapharma USA, Inc.5$114
Lilly USA, LLC6$105
Intercept Pharmaceuticals, Inc.6$95
Catalyst Pharmaceuticals, Inc.5$95
Sunovion Pharmaceuticals Inc.7$87
Xeris Pharmaceuticals, Inc.6$87
Pfizer5$87
Sandoz4$84
GE HealthCare8$82
Bristol Myers Squibb5$73
Kyowa Kirin, Inc.4$65
Azurity Pharmaceuticals, Inc.4$56
Otsuka America Pharmaceutical, Inc.2$50
Averitas Pharma Inc.2$46
Abbott2$39
Grifols USA, LLC1$32
Idorsia Pharmaceuticals US Inc2$31
Madrigal Pharmaceuticals1$28
Impel Pharmaceuticals LLC2$27
Sanofi-aventis U.S. LLC1$25
Acorda Therapeutics, Inc2$25
Adamas Pharmaceuticals, Inc.1$17
Celltrion USA Inc.1$17

How this compares

$19,326 in reported general payments places this provider in the 95th percentile of 97 clinical nurse specialist providers in Ohio.

See all clinical nurse specialist providers in Ohio →

Medicare billing

Part B allowed, 2024
$22,932
Medicare patients
214
Services billed
290

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Other clinical nurse specialist in Akron

See the full list for Ohio →

Where these figures come from

Is this you, or does something look wrong? →